Problem statement: Answer the multiple choice question.
Query: Which drug has a -5.310% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCOc1ccc(C(=O)N2CCN(S(=O)(=O)c3cccs3)CC2)c(OCC)c1
b CCc1ccc(-n2nnnc2SCC(=O)NNC(=O)c2ccco2)cc1
c CCC(C)c1ccc(NC(=O)N2CCN(C(=O)C3CCCO3)CC2)cc1
Answer: c. CCC(C)c1ccc(NC(=O)N2CCN(C(=O)C3CCCO3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)c1ccc(NC(=O)N2CCN(C(=O)C3CCCO3)CC2)cc1
CCC(C)c1ccc(NC(=O)N2CCN(C(=O)C3CCCO3)CC2)cc1
N-(4-butan-2-ylphenyl)-4-(oxolane-2-carbonyl)piperazine-1-carboxamide